Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183,255,226
-
Number of holders
-
187
-
Total 13F shares, excl. options
-
87,463,202
-
Shares change
-
+4,399,534
-
Total reported value, excl. options
-
$2,768,171,136
-
Value change
-
+$131,977,881
-
Put/Call ratio
-
30%
-
Number of buys
-
104
-
Number of sells
-
89
-
Price
-
$31.65
Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q3 2018
As of 30 Sep 2018 HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) had 187 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 87,463,202 shares of stock of the company.
Largest 10 holders included FMR LLC, Vanguard Group Inc, TANG CAPITAL MANAGEMENT LLC, FRANKLIN RESOURCES INC, JANUS HENDERSON GROUP PLC, BAKER BROS. ADVISORS LP, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, and FIL Ltd.
This table shows 187 institutional shareholders of the security as of 30 Sep 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.